Clari Vest Asset Management LLC Abb Vie Inc. Transaction History

Clari Vest Asset Management LLC

$944 Million
Q1 2024

A detailed history of Clari Vest Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 44,330 shares of ABBV stock, worth $7.6 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

44,330

Previous 147,143 69.87%

Holding current value

$7.6 Million

Previous $22.8 Million 64.6%

% of portfolio

0.85%

Previous 1.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $16.4 Million - $18.7 Million	-102,813 Reduced 69.87%	44,330 $8.07 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $3.44 Million - $3.88 Million	-25,022 Reduced 14.53%	147,143 $22.8 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.88 Million - $2.18 Million	-14,066 Reduced 7.55%	172,165 $25.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $4.57 Million - $5.69 Million	-34,500 Reduced 15.63%	186,231 $25.1 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $1.29 Million - $1.48 Million	-8,906 Reduced 3.88%	220,731 $35.2 Million

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $822,944 - $986,926	-5,950 Reduced 2.53%	229,637 $37.1 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.88 Million - $2.16 Million	-14,000 Reduced 5.61%	235,587 $31.6 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.49 Million - $1.9 Million	-10,852 Reduced 4.17%	249,587 $38.2 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $1.36 Million - $1.69 Million	10,300 Added 4.12%	260,439 $42.2 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $703,559 - $890,205	-6,549 Reduced 2.55%	250,139 $33.9 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $694,047 - $787,847	-6,523 Reduced 2.48%	256,688 $27.7 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $1.43 Million - $1.59 Million	-13,592 Reduced 4.91%	263,211 $29.6 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $3.04 Million - $3.35 Million	-29,720 Reduced 9.7%	276,803 $30 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $3.9 Million - $5.26 Million	-48,407 Reduced 13.64%	306,523 $32.8 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $1.09 Million - $1.28 Million	-12,681 Reduced 3.45%	354,930 $31.1 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $5.25 Million - $7.02 Million	-71,498 Reduced 16.28%	367,611 $36.1 Million
Q1 2020 May 04, 2020	SELL	$64.5 - $97.79 $1.93 Million - $2.93 Million	-29,949 Reduced 6.38%	439,109 $33.5 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $2.91 Million - $3.64 Million	-40,301 Reduced 7.91%	469,058 $41.5 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $7.25 Million - $8.72 Million	115,106 Added 29.2%	509,359 $38.6 Million
Q2 2019 Aug 16, 2019	SELL	$65.7 - $83.98 $1.78 Million - $2.28 Million	-27,154 Reduced 6.44%	394,253 $28.7 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $8.77 Million - $10.3 Million	-113,677 Reduced 21.24%	421,407 $34 Million
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $2.04 Million - $2.51 Million	-26,151 Reduced 4.66%	535,084 $49.3 Million
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $3.51 Million - $3.9 Million	-39,491 Reduced 6.57%	561,235 $53.1 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $4.09 Million - $4.84 Million	-45,586 Reduced 7.05%	600,726 $55.7 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $1.45 Million - $1.95 Million	-15,801 Reduced 2.39%	646,312 $61.2 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $27.5 Million - $30.2 Million	307,548 Added 86.74%	662,113 $64 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $1.01 Million - $1.29 Million	-14,408 Reduced 3.9%	354,565 $31.5 Million
Q2 2017 Nov 20, 2017	BUY	N/A	368,973	368,973 $26.8 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Account

Clari Vest Asset Management LLC Abb Vie Inc. Transaction History